DocuSign (NASDAQ:DOCU) was downgraded by research analysts at UBS Group from a “buy” rating to a “neutral” rating in a report issued on Friday, Analyst Price Targets reports. They presently have a $170.00 target price on the stock, down from their previous target price of $350.00. UBS Group’s target price indicates a potential upside of 25.84% from the company’s previous close.